Written question asked by Paul Beresford (Conservative) on Tuesday, 17 July 2012, in the House of Commons. It was due for an answer on Monday, 3 September 2012. It was answered by Paul Burstow (Liberal Democrat) on Monday, 3 September 2012 on behalf of the Department of Health.
Cancer
- Question
-
To ask the Secretary of State for Health (1) what recent assessment he has made of the availability of the National Institute for Health and Clinical Excellence-approved treatments for (a) lung, (b) bowel and (c) breast cancer in Surrey Primary Care Trust;
[118373]
- Answer
-
We have made no assessment of the availability of National Institute for Health and Clinical Excellence (NICE) approved treatments for lung, bowel and breast cancer at a national or at primary care trust (PCT) level.
PCTs are legally obliged to fund drugs and treatments recommended in NICE technology appraisal guidance, within three months of guidance being published; unless the requirement is waived in a specific case.
Secondary information
- Type
- Written question
- Reference
- 118373; 549 c239W
- Session
- 2012-13
- Subjects
- Breast cancer Cancer Surrey Lung cancer Bowel cancer
- Link
- View this Written question on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2014-01-14 18:50:58 +0000
- URI
- http://hansard.intranet.data.parliament.uk/Commons/2012-09-04/12090429002127
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Commons/2012-09-04/12090429002127
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Commons/2012-09-04/12090429002127